Tobacco Center Faculty Blog

August 11, 2020

Stanton A. Glantz, PhD

There have been several reports, mostly in non-peer reviewed preprints, reporting lower levels of COVID-19 infections among smokers than nonsmokers. This is a surprising finding because, based on what we know about the effects of smoking and vaping on immune function of the respiratory system, one would expect that smoking and vaping would increase risks of COVID infection.

A big problem with all the studies to date has been that they have been based on people who were tested, rather than samples drawn from the population as a whole.  Because of limited availability of tests in many places, the resulting samples are biased toward people who may already have symptoms.

August 5, 2020

Stanton A. Glantz, PhD

Senator Jerry Hill’s SB 793 made it out of the Assembly Health Committee relatively unscathed and is now heading to Assembly Appropriations for one last hearing before going to the full Assembly.  (It already passed the Senate.)

Thanks to a massive tobacco industry mobilization, Sen Hill had to accept narrow amendments to exempt premium cigars and pipe tobacco (in addition to previous amendments exempting hookah), but the large health coalition was able to keep menthol and all other cigars in the bill. 

Keeping most cigars in the bill – including little cigars popular with poor kids – was particularly important.

July 28, 2020

Stanton A. Glantz, PhD

Steve Anderson and Jim Lightwood just published Health Care Cost Savings Attributable to the California Tobacco Control Program, 1989 to 2018 through the University of California eScholarship initiative.  Using sophisticated econometric analysis they convincingly show that in its first 30 years, the program reduced actual medical costs by a total of $500 billion (in 2019 dollars). 

In 2019, California medical costs were about $37 billion below what one would have expected had the voters not passed Prop 99 in 1988.  At a time that California, like all states, is struggling with the financial challenges created by the coronavirus epidemic, the California Tobacco Program (CTCP) is not only saving lives but also making a substantial contribution to helping California meet its current financial challenges.

This amount only includes medical care costs (doctors, hospitals, drugs, and related costs), not indirect costs such as lost productivity or the value of lives lost.   The savings in those areas are generally even more than the direct medical costs.

Moreover, using an alternative measure of medical costs, the Center for Medicare and Medicaid Services, the estimated savings are even higher: $737 billion.

July 27, 2020

Stanton A. Glantz, PhD

Here is what the WHO had to say:

WHO takes this opportunity to remind Member States that are Parties to the WHO Framework Convention of Tobacco Control (FCTC) of their obligations under the Convention. Heated tobacco products are tobacco products, meaning that the WHO FCTC fully applies to these products. (Decision FCTC/COP8(22)) Specifically, Article 13.4(a) obliges Parties, to prohibit "all forms of tobacco advertising, promotion and sponsorship that promote a tobacco product by any means that are false, misleading or deceptive or likely to create an erroneous impression about its characteristics, health effects, hazards or emissions."

WHO reiterates that reducing exposure to harmful chemicals in Heated Tobacco Products (HTPs) does not render them harmless, nor does it translate to reduced risk to human health. Indeed, some toxins are present at higher levels in HTP aerosols than in conventional cigarette smoke, and there are some additional toxins present in HTP aerosols that are not present in conventional cigarette smoke. The health implications of exposure to these are unknown.

Pages